腺苷药物预适应对缺血心肌的保护作用(3)
 |
| 第1页 |
参见附件。
[4]McCullyJD,ToyodaY,UematsuM,etal.Adenosine-enhancedischemicpreconditioning:adenosinereceptorinvolvementduringischemiaandreperfusion[J].AmJPhysiolHeartCircPhysiol,2001,280(2):H5912-6021.
[5]LeeHT,EmalaCW.Preconditioningandadenosineprotecthumanproximaltubulecellsinaninvitromodelofischemicinjury[J].JAmSocNephrol,2002,13(11):2753-2761.
[6]YamashitaN,NishidaS,HoshidaJ,etal.Alpha1-adrenergicstimulationinducescardiactolerancetohypoxiaviainductionandactivationofMn-SOD.AmJPhysiol,1996,271:H1356-1362.
[7]QinQ,YangXM,Cuil,etal.ExogenousNOtriggerspreconditioningviaaCGMP-andmito-KATP-dependentmechanism.[J].AmJPhysiolHeartCircPhysiol.2004Aug;287(2):H712-8.
[8]BergesA,VanNassauwL,BosmansJ,etal.Roleofnitricoxideandoxidativestressinischemicmyocardialinjuryandpreconditioning[J].ActaCardiol.2003Apr;58(2):119-32
[9]GuoY,SteinAB,WuWJ,etal.LatepreconditioninginducedbyNOdonors,adenosineA1receptoragonists,anddelta1-opioidreceptoragonistsismediatedbyINOS[J].AmJPhysiolHeartCircPhsiol.2005Nov;289(5):H2251-7.
[10]DasS,AlagappanVK,BagchiD,etal.CordinatedinductionofiNOS-VEGF-KDF-eNOSafterreseratrolconsuption:apotentialmechanismforreseratrolpreconditioningoftheheart[J].VasculPharmacol.2005Apr-May;42(5-6):281-9.
[11]SaurinAT,MartinJL,HeadsRJ,etal.Theroleofdifferentialactivationofp38-mitogen-activatedproteinkinaseinpreconditionedventricularmyocytes[J].FASEB,2000,14(14):2237-2246.
[12]NakanoA,BainesCP,KimSO,etal.IschemicpreconditioningactivatesMAPKAPK2intheisolatedrabbitheart:evidenceforinvolvementofp38MAPK[J].CircRes,2000,86(2):1442151.
[13]MocanuMM,BaxterGF,YueY,etal.Thep38MAPKinhibitor,SB203580,abrogatesischemicpreconditioninginratheartbuttimingofadministrationiscritical[J].BasicResCardiol,2000,95(6):472-478.
您现在查看是摘要介绍页，详见PDF附件(5760kb)。